Singapore, June 15 -- As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufacturing technologies to the operational foundations that under... Read More
Singapore, June 15 -- A research team from The Hong Kong University of Science and Technology (HKUST), together with an HKUST-incubated medtech startup, PhoMedics Limited, has developed Glanzir(R), th... Read More
Singapore, June 15 -- South Korea-based OliX Pharmaceuticals, a leading developer of RNAi therapeutics, has raised approximately KRW 110 billion through a third-party allotment of newly issued common ... Read More
Singapore, June 15 -- QR678(R), a patented, global, scalp science and regenerative hair regeneration research platform focused on structured biological signalling approaches in hair and scalp wellness... Read More
Singapore, June 15 -- Vietnam-based IT outsourcing and software development company Kaopiz Holdings and Singapore-based health technology company QuantumTX have announced a strategic Memorandum of Und... Read More
Singapore, June 15 -- Qiagen N.V. has announced new additions to its QIAcuity digital PCR (dPCR) ecosystem, with a focus on expanding gene expression capabilities, broadening assay content and enhanci... Read More
Singapore, June 12 -- China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US to jointly advance an exploratory study in the respiratory... Read More
Singapore, June 12 -- The National University Hospital (NUH) and LASALLE College of the Arts, University of the Arts Singapore (LASALLE) have established a first-of-its-kind Sustainable Medicine Desig... Read More
Singapore, June 12 -- Japan's Lotte Holdings has announced an investment in ClearideBio Therapeutics AG, an early-stage biotechnology startup pioneering next-generation antibody-drug conjugates (ADCs)... Read More
Singapore, June 12 -- Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with South Korea's Samil Pharmaceuticals, for exclusive rights to the commercialisation of ... Read More